Clinical Trials Browser

Carcinoma, Ovarian Epithelial, Genital Neoplasms, Female, Neoplasms, Neoplasms, Glandular and Epithelial, Ovarian Diseases, Ovarian Neoplasms, Stomach Neoplasms, Urogenital Neoplasms

NCT04294836 2022-12-07

Curcumin in Advanced Cervical Cancer

Phase 2 Withdrawn

Gynecologic

Uterine Cervical Neoplasms

NCT05597527 2022-10-28

Fluzopari Combined With Apatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer

Phase 2 Unknown

35 enrolled

Gynecologic

Ovarian Neoplasms

NCT04475159 2020-07-17

Combined Neoadjuvant Systemic and PIPAC Therapy (NASPIT) for Patients With Colorectal Peritoneal Metastasis Eligible for CRS and HIPEC: A Prospective Phase II Trial

Phase 2 Unknown

50 enrolled

GastrointestinalGynecologic

Colonic Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms

NCT03942068 2019-05-08

Apatinib With Albumin-bound Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer

Phase 2 Unknown

35 enrolled

Gynecologic

Ovarian Neoplasms

NCT03412526 2019-04-04

Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Ovarian

Phase 2 Unknown

15 enrolled

Gynecologic

Ovarian Neoplasms

NCT03546855 2018-06-06

Apatinib Treating Patients With Advanced Cervical Cancer After Radiotherapy and First-line Chemotherapy.

Phase 2 Unknown

69 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT03547375 2018-06-06

Clinical Study of Apatinib in the Treatment of Advanced Ovarian Cancer After the Failure of Standard Chemotherapy

Phase 2 Unknown

69 enrolled

Gynecologic

Ovarian Neoplasms

NCT01669226 2016-12-19

AICE

Phase 2 Completed

215 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02562729 2016-10-14

Complete Nerve-Sparing Radical Hysterectomy for Cervical Cancer

Phase 2 Completed

62 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT02595021 2016-07-26

Total/Subtotal Colectomy in Ovarian Cancer

Phase 2 Unknown

80 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01367639 2013-11-25

Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers

Phase 2 Completed

67 enrolled

BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

NCT00430144 2012-04-26

Belotecan (CKD-602) in Recurrent or Progressive Carcinoma of Uterine Cervix

Phase 2 Completed

16 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT00147680 2012-02-02

Uterine Papillary Serous Cancer (UPSC) Trial

Phase 2 Completed

30 enrolled

Gynecologic

Uterine Neoplasms

NCT01117402 2010-05-05

Tomotherapy in Postsurgery Recurrent Carcinoma Cervix

Phase 2 Unknown

90 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT00404326 2006-11-28

Hydralazine and Valproate Plus Cisplatin Chemoradiation in Cervical Cancer

Phase 2 Completed

18 enrolled

Gynecologic

Uterine Cervical Neoplasms

Clinical Trials

KOV-02S

OC-POP-PT

Assessment of Gemcitabine as Chemoradiotherapy in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease

Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer

SATELLITE

Trichlosil

Adebrelimab Combined with Non-platinum Chemotherapy and Fuzuloparib in Recurrent Platinum-resistant Ovarian Cancer

feMMe

Efficacy and Safety of AK104 Combined With Chemotherapy and Recombinant Human Adenovirus 5 Injection in Cervical Cancer

Nituzumab Plus Serplulimab Combined With SBRT in Cervical Cancer

Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer

Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer

Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer

Curcumin in Advanced Cervical Cancer

Fluzopari Combined With Apatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer

Combined Neoadjuvant Systemic and PIPAC Therapy (NASPIT) for Patients With Colorectal Peritoneal Metastasis Eligible for CRS and HIPEC: A Prospective Phase II Trial

Apatinib With Albumin-bound Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer

Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Ovarian

Apatinib Treating Patients With Advanced Cervical Cancer After Radiotherapy and First-line Chemotherapy.

Clinical Study of Apatinib in the Treatment of Advanced Ovarian Cancer After the Failure of Standard Chemotherapy

AICE

Complete Nerve-Sparing Radical Hysterectomy for Cervical Cancer

Total/Subtotal Colectomy in Ovarian Cancer

Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers

Belotecan (CKD-602) in Recurrent or Progressive Carcinoma of Uterine Cervix

Uterine Papillary Serous Cancer (UPSC) Trial

Tomotherapy in Postsurgery Recurrent Carcinoma Cervix

Hydralazine and Valproate Plus Cisplatin Chemoradiation in Cervical Cancer